Atlas Trials

Study of a Novel Subcutaneous Depot Formulation of Buprenorphine

Clinical trial NCT03715634 · COMPLETED

Trial details

NCT number
NCT03715634
Sponsor
Indivior Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid-use Disorder
Start date
2017-09-20
Primary completion
2018-06-07
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.